Contact

§ I · What we respond to

What we respond to

The editorial desk welcomes correspondence on three subjects. The first is corrections — if a citation in Chapter V is mis-attributed, if a dose figure is mis-transcribed from a trial, if a date or number on any page is wrong, we want to know. The second is citation updates — new peer-reviewed research, regulatory determinations, or review articles that materially extend or revise the existing literature. The third is factual queries — clarifying questions about something stated on the site that may benefit from additional context.

We do not respond to medical inquiries. Questions about whether sermorelin would be appropriate for a particular reader, what dose to use, what laboratory values to target, what symptoms to expect, or what telemedicine provider to consult are outside our scope and beyond our professional remit. Such questions should be directed to a licensed clinician.

§ II · Correspondence form

Correspondence form

Use the form below to send correspondence to the editorial desk. Please include the page and section reference where applicable, the nature of the correction or query, and a contact address. We read every submission; we cannot promise an individual reply but corrections that survive editorial review are typically incorporated into the next compendium revision.

§ III · Disclaimer of medical advice

Disclaimer of medical advice

This site is editorial commentary on the published sermorelin research literature. It is not medical advice. It does not establish a clinician-patient relationship. The site does not sell any product, does not prescribe, does not dispense, and is not affiliated with any compounding pharmacy or telemedicine provider. Any reader considering sermorelin for any purpose should consult an appropriately licensed clinician before taking action.